Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.00 is 78% below its 5-year average of 13.73, near the low end of its 5-year range (0.17–42.30).
As of the fiscal period ended Tuesday, June 30, 2026. 162.10% above its 12-month average of 1.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.00.
QUICK RATIO (ACID-TEST)
3.00
QUICK RATIO (ACID-TEST) AVG TTM
1.15
QUICK RATIO (ACID-TEST) AVG 3Y
4.65
QUICK RATIO (ACID-TEST) AVG 5Y
13.73
QUICK RATIO (ACID-TEST) AVG 10Y
9.75
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+162.10%
CURRENT VS 3Y AVG
-35.42%
CURRENT VS 5Y AVG
-78.11%
CURRENT VS 10Y AVG
-69.18%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 741 covered companies
CURRENT VS SECTOR MEDIAN
-5.83%
vs the sector median at left
Artelo Biosciences, Inc.
Market Cap
$1.40M
Quick Ratio (Acid-Test)
3.00
TTM Avg
1.15
3Y Avg
4.65
5Y Avg
13.73
Market Cap
$1.45M
Quick Ratio (Acid-Test)
0.67
TTM Avg
0.15
3Y Avg
0.14
5Y Avg
1.64
Market Cap
$1.47M
Quick Ratio (Acid-Test)
7.70
TTM Avg
0.13
3Y Avg
0.13
5Y Avg
0.13
Market Cap
$1.47M
Quick Ratio (Acid-Test)
1.30
TTM Avg
2.54
3Y Avg
2.69
5Y Avg
2.23
Market Cap
$1.24M
Quick Ratio (Acid-Test)
0.62
TTM Avg
1.47
3Y Avg
0.74
5Y Avg
0.53
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.40M | 3.00 | 1.15 | 4.65 | 13.73 |
| NEXGEL, Inc. (NXGL)vs › | $1.41M | 0.27 | 1.06 | 2.93 | 2.76 |
| Genprex, Inc. (GNPX)vs › | $1.36M | 6.77 | 2.33 | 3.65 | 16.80 |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | 0.67 | 0.15 | 0.14 | 1.64 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.47M | 7.70 | 0.13 | 0.13 | 0.13 |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.32 | 1.73 | 1.61 | 1.48 |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 1.30 | 2.54 | 2.69 | 2.23 |
| Curis, Inc. (CRIS)vs › | $1.48M | 0.49 | 0.94 | 3.46 | 6.68 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.24M | 0.62 | 1.47 | 0.74 | 0.53 |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | 2.55 | 2.02 | 1.02 | 0.68 |
Quick Ratio
3.00
Excludes inventory
Current Ratio
3.00
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.00 |
| 2026-03-31 | 1.79 |
| 2025-12-31 | 0.17 |
| 2025-09-30 | 0.38 |
| 2025-06-30 | 0.39 |
| 2025-03-31 | 0.49 |
| 2024-12-31 | 1.44 |
| 2024-09-30 | 7.15 |
| 2024-06-30 | 6.56 |
| 2024-03-31 | 11.36 |
| 2023-12-31 | 8.51 |
| 2023-09-30 | 14.58 |
| 2023-06-30 | 24.22 |
| 2023-03-31 | 19.86 |
| 2022-12-31 | 18.36 |
| 2022-09-30 | 42.30 |
| 2022-06-30 | 42.28 |
| 2022-03-31 | 28.10 |
| 2021-11-30 | 23.96 |
| 2021-08-31 | 19.61 |
| 2021-05-31 | 24.30 |
| 2021-02-28 | 19.36 |
| 2020-11-30 | 15.44 |
| 2020-08-31 | 4.66 |
| 2020-05-31 | 5.41 |
| 2020-02-29 | 4.75 |
| 2019-11-30 | 6.00 |
| 2019-08-31 | 4.35 |
| 2019-05-31 | 1.13 |
| 2019-02-28 | 0.41 |
| 2018-11-30 | 0.26 |
| 2018-08-31 | 0.75 |
| 2018-05-31 | 0.81 |
| 2018-02-28 | 3.47 |
| 2017-11-30 | 3.15 |
| 2017-08-31 | 19.51 |
| 2017-05-31 | 0.67 |
| 2017-02-28 | 0.41 |
| 2016-11-30 | 0.36 |
| 2016-08-31 | 0.21 |
| 2016-05-31 | 0.27 |
| 2016-02-29 | 0.45 |
| 2015-11-30 | 9.79 |
| 2015-08-31 | 9.79 |
| 2015-05-31 | 0.00 |
| 2015-02-28 | 5.39 |
| 2014-11-30 | 0.00 |
| 2014-08-31 | 0.00 |
| 2014-05-31 | 0.00 |
| 2014-02-28 | 0.00 |
| 2013-11-30 | 0.00 |
